Annual Report

Overview

The report describes Rua's FY22 progress from a pre-revenue medicinal cannabis start-up toward commercialisation, including GMP certification and the launch of its first New Zealand medicine. It highlights the acquisition of Zalm Therapeutics, which secured access to Cann Group's GMP-grade supply, and advances in Germany and Europe. Sustainability work began with a carbon transition plan, operational emissions measurement under ISO 14064-1 and a Toitū Envirocare journey. Community programmes included ten scholarships for local students.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2022
Period: Ends 30 June 2022
Publication date: 14 September 2022
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services